GSK Opens Pneumonia Vaccine Plant In Singapore

GSK Opens Pneumonia Vaccine Plant In Singapore
Drug maker GlaxoSmithKline (GSK) on Tuesday opened a $600 million plant in Singapore that is slated to begin producing vaccines to fight pneumonia-causing bacteria in 2011, Reuters reports.